Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock
06/10/2026 01:15
BRIEF-Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock Oct 5 (Reuters) - Spyre Therapeutics Inc SYRE.O:
SPYRE THERAPEUTICS ANNOUNCES PRICING OF $350.0 MILLION PUBLIC OFFERING OF COMMON STOCK
SPYRE THERAPEUTICS - PRICES PUBLIC OFFERING OF 4,117,648 SHARES AT $85 PER SHARE
Source text: ID:nGNX5Kslrs
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock